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Contractile Reserve and Coronary
Blood Flow Reserve in Collateral-
Dependent Myocardium*
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Chicago, Illinois
Numerous studies in recent years have clearly demonstrated
that viable myocardium with contractile dysfunction main-
tains a contractile reserve that can be unmasked by inotropic
stimulation, such as by the infusion of low doses of
dobutamine. Hence, low-dose dobutamine echocardiogra-
phy (LDDE) has become firmly established as a diagnostic
tool in patients with coronary artery disease (CAD) and left
ventricular (LV) dysfunction as a means to differentiate
hibernating and stunned myocardium from irreversibly
damaged myocardium. The available data indicate that
function and flow remain coupled in reversibly dysfunc-
tional myocardium, so that the increases in myocardial
oxygen demand associated with inotropic stimulation are
accompanied by increases in myocardial perfusion. Indeed,
preserved coronary blood flow reserve is believed to be a
requisite for contractile reserve.
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In stunned myocardium arising from reperfusion after
coronary occlusion, coronary blood flow reserve is usually
maintained in response to increases in myocardial demand,
although microvascular stunning may attenuate vasodilator
responsiveness. Similarly, in hibernating myocardium, cor-
onary blood flow is reduced at rest and blood flow reserve is
present but attenuated (1–3), which has been measured
directly in patients with radiolabeled microspheres and
quantitative positron emission tomography (PET). Such
attenuated coronary blood flow responsiveness has also been
demonstrated quantitatively by PET in myocardium that is
totally dependent on collateral blood flow (4,5). This
augmentation of flow in hibernating myocardium in re-
sponse to vasodilator stimuli (1,4,5) and increases in myo-
cardial demand (2,5) averages 40% to 50% (significantly
lower than that of normal myocardium) and may be con-
siderably lower in individual patients. Standard myocardial
perfusion imaging using single photon emission tomogra-
phy (SPECT), which has reduced resolution and sensitivity
compared with PET and lacks the quantitative capabilities
of PET, may identify augmented myocardial blood flow in
response to inotropic stimulation in many patients with
hibernating myocardium, but it is unlikely that SPECT will
be sensitive enough to detect those patients with more
subtle increases in blood flow, as might occur in patients
with a relative paucity of collateral channels.
As hibernating myocardium represents a delicate balance
between flow, function and viability, it is also quite likely
that the increased demands of inotropic stimulation in some
patients will overwhelm the limited flow reserve and result
in myocardial ischemia. This may explain, in part, the
reduced sensitivity of LDDE to detect viable but underper-
fused myocardium compared with perfusion imaging (6),
because the myocardial regions with the most reduced basal
blood flow and exhausted blood flow reserve may not be able
to increase contractility at even low levels of demand. This
also explains the common finding of a biphasic response to
dobutamine (7,8), in which low dose dobutamine elicits an
increase in regional systolic wall thickening, but higher
doses exhaust flow reserve and produce ischemia, resulting
in a reduction in wall thickening toward baseline values.
A more controversial concept is whether inotropic stim-
ulation can cause ongoing augmentation of transmural
systolic function after exhaustion of flow reserve and during
active ischemia, particularly in the subendocardial regions.
Experimental models of short-term myocardial hibernation
indicate that dobutamine may produce subendocardial isch-
emia while continuing to increase transmural wall thicken-
ing (9,10) and that this may even lead to subendocardial
necrosis (10). Hence, caution has been raised about the use
of dobutamine for diagnostic testing in patients with critical
coronary artery stenoses and for inotropic support during
acute myocardial infarction (3). One might also consider the
potential hazards of inotropic support for the short-term
management of patients with decompensated heart failure,
the majority of whom have CAD (11).
Evidence in support of such concern is provided by
quantitative PET studies in patients with viable myocar-
dium with reduced perfusion and systolic function. Sam-
buceti et al. (5) reported augmented myocardial blood flow
in patients with collateral-dependent myocardium in re-
sponse to both increased demand (atrial pacing) and vaso-
dilator stimuli (dipyridamole). However, the magnitude of
the increased in flow varied considerably among patients,
and transmural blood flow actually decreased in some
patients in response to atrial pacing, with the likelihood of
an even greater decrease in the subendocardial layer. Re-
duced perfusion during the increased demand of tachycardia
presumably represents ischemia. Reduced transmural vaso-
dilator reserve in that study was most evident in patients
with poorly developed compared with those with well
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developed collateral channels visualized at angiography (5).
Sun et al. (2) demonstrated that increase in contractility
induced by dobutamine is associated with either no change
or a decrease in quantitative glucose use in normally per-
fused regions of patients with CAD and LV dysfunction, as
it is in normal control subjects. However, in viable regions
characterized under basal conditions by reduced wall motion
and reduced blood flow with metabolism-blood flow “mis-
match,” the increases in wall motion and blood flow during
dobutamine were associated with an increase in glucose use.
Although this effect could represent a metabolic perturba-
tion resulting from altered beta-receptor density or function
in hibernating myocardium (which has not been previously
described), this pattern also fits the well-established meta-
bolic fingerprint of acute myocardial ischemia (12).
The study of Barilla` et al. in this issue of the Journal (13)
adds further support to the concept that inotropic stimula-
tion may augment contractile function in reversibly dysfunc-
tional myocardium without an appropriate increase in trans-
mural myocardial blood flow. Among patients with reduced
regional myocardial function and perfusion (as assessed by
Tc-99m-sestamibi SPECT) after acute myocardial infarc-
tion, those with well developed collateral vessels visualized
at angiography manifested significant increases in myocar-
dial blood flow and contractile function during LDDE,
which translated in the majority of patients into improve-
ments in wall motion after myocardial revascularization.
This finding would be expected. The important and unique
observation was that many regions with poorly developed
collateral vessels also manifested contractile reserve with
LDDE, but with no measurable flow response; most pa-
tients showed recovery of both regional wall motion and
myocardial blood flow reserve after revascularization.
The patients studied by Barilla` et al. seem to represent a
spectrum of acute or short-term myocardial hibernation (14)
rather than pure stunning, because they had a critical
stenosis (.90% luminal narrowing) in the infarct-related
artery with reduced blood flow at rest and the improvement
in wall motion was not spontaneous but was accomplished
only after revascularization. There are several implications
of their findings. First, contractile responsiveness to dobut-
amine may occur in this setting without an augmentation in
transmural flow, suggesting a dissociation of the flow-
function relationship, exhaustion of coronary flow reserve
and at least subendocardial ischemia. These data seem to
contradict previous PET studies indicating that hibernating
myocardium has preserved but attenuated blood flow reserve
to inotropic stimuli (2,4,5). Although this apparent differ-
ence may be explained by the selection of patients with
short-term hibernation by Barilla` et al. rather than patients
with chronic LV dysfunction (which was the case in the
previous PET studies), this difference may also be explained
by technical issues, noted in the following section. From a
more practical perspective, the current data also raise the
possibility that LDDE may have greater accuracy for
predicting recovery of wall motion after revascularization in
patients with short-term hibernation than does myocardial
perfusion imaging. However, the perfusion imaging proto-
col was not designed to optimize the accuracy of SPECT
imaging for detecting ischemia, viability or flow reserve, as
sestamibi was injected during low dose, rather than maxi-
mal, inotropic stimulation. It is also noteworthy that LDDE
in the current study failed to predict recovery of wall motion
after revascularization with the same accuracy that has been
reported in previous studies of patients with CAD and
chronic LV dysfunction (6) and patients with LV dysfunc-
tion after myocardial infarction (15,16). Combining the 115
myocardial segments with systolic dysfunction in groups A
and B in the study of Barilla` et al. (13), LDDE achieved a
sensitivity and specificity of only 69% and 60%, respectively,
for predicting improved regional wall motion after revascu-
larization, with calculated positive and negative predictive
accuracies of only 76% and 51%, respectively. The low
specificity (but not the low sensitivity) may be related to the
short follow-up time (mean 40 days) after revascularization,
as LV function may continue to improve between 5 weeks
and 7 months (17).
In addition to the short follow-up period, several other
aspects of the study of Barilla` et al. limit full interpretation
of the results leading to their conclusions. Grading the
degree of coronary collateral development by angiography
has notorious difficulty and imprecision. The authors con-
sidered only well-developed collaterals (grade 3) as evidence
of collateral flow. Although this establishes that collateral
flow was indeed present in the group defined as showing
collaterals, it leaves open the distinct possibility that collat-
erals were also present, but less well developed, in the
majority of the group considered “without” collateral vessels.
There clearly was sufficient blood flow through antegrade or
collateral channels to maintain tissue viability and presum-
ably to allow for an increase in transmural contractility in
response to dobutamine. Second, because heart rate and
blood pressure data are not provided, it is unclear whether
the increase in myocardial demand with dobutamine was
similar between the groups with and without well-
established collaterals. Although both groups showed in-
creased contractility as evidence of increased demand, dif-
ferences in rate–pressure product between the two groups
could influence the level of demand and hence the appro-
priateness of any flow increase. A third issue is the use of
sestamibi SPECT imaging to assess regional coronary blood
flow reserve. Analysis of sestamibi images provides only
relative flow information. In the absence of methods to
calculated absolute flow (as can be performed with PET) a
flow increase in the hibernating region may go undetected
by SPECT imaging if dobutamine produces a similar degree
of augmented blood flow to normal regions. It is likely that
small increases in blood flow of 10% to 20%, which
frequently occur in response to pacing tachycardia or do-
butamine (2,5), cannot be detected by SPECT methods,
especially when flow is also increasing in normal regions.
SPECT also lacks the resolution to determine whether
706 Bonow JACC Vol. 33, No. 3, 1999
Editorial Comment March 1, 1999:705–7
there is a differential flow response between the endocar-
dium and epicardium in response to dobutamine.
The observations of Barilla` et al. provide a basis for
further thought and investigation of the coupling and
uncoupling of flow and function in myocardium with
reversible contractile dysfunction. Prospectively designed
studies to evaluate functional and flow responses to ino-
tropic stimulation should provide further insights, but these
will require application of quantitative methods to deter-
mine absolute blood flow. Although PET can provide such
data, the spatial resolution of PET cannot differentiate
changes in transmural flow distribution from endocardium
to epicardium. To fully address the possibility of uncoupling
of flow and function during inotropic stimulation, methods
that can evaluate flow-function relationships at the endo-
cardial and epicardial levels, such as contrast echocardiog-
raphy or contrast magnetic resonance imaging, will be
required. The development of such methods should prove to
be important investigative tools as new treatments to in-
crease collateral blood flow to ischemic and dysfunctional
myocardium, such as laser revascularization and therapies to
stimulate angiogenesis, continue to evolve.
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